A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease
Status:
Completed
Trial end date:
2017-12-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of
KHK6640, given as a repeated dose in Japanese patients with Mild to Moderate Alzheimer's
Disease.